FDA mulls compounding for peptides previously flagged over safety risks BioSpace BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 (compounding only, no legal prescribing) into Category 1. This means FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved BPC 157 & TB 500 Blend 10mg 10mg Peptide Tech